Results 141 to 150 of about 24,398 (299)
Plasmon Tunability of Gold Nanostars at the Tip Apexes
ACS Omega, 2018 Nicolas Pazos-Perez +2 more
doaj +1 more source
Advanced therapy medicinal products (ATMPs) – An analysis of the global regulatory status
British Journal of Clinical Pharmacology, EarlyView.Abstract Background A rapid progress in the development of advanced therapy medicinal products (ATMPs) has taken place over the past decades. The ATMPs hold great potential but face challenges in the clinical development and the regulatory process.
Allan Cramer +4 more
wiley +1 more source
British National Formulary Guidance on prescribing in pregnancy: A descriptive cross‐sectional study
British Journal of Clinical Pharmacology, EarlyView.Aim To assess how well pregnancy‐specific guidance within the British National Formulary supports healthcare professionals to facilitate safe and effective medication use. Methods We performed a manifest content analysis of the text of all pregnancy sections within British National Formulary drug monographs, with inductive and iterative coding.
Hannah Johnson +9 more
wiley +1 more source
The EMAS 2006/2007 update on clinical recommendations on postmenopausal hormone therapy
, 2007 This new statement from EMAS presents the findings reported in recent publications from both WHI trials. In general, the reports do not necessitate a revision of the current EMAS advice.
Rozenberg, S +8 more
core
KRITIK PENETAPAN HARGA IJARAH PADA GADAI EMAS (TINJAUAN FIKIH DAN ETIKA)
Jurnal Hukum Islam, 2013 Pembiayaan gadai emas di bank syariah mencuat ketika harga emas dunia mengalami fluktuasi yang cukup tajam. Hal ini mendorong masyarakat beralih kepada investasi emas.
Rinda Asytuti
doaj
British Journal of Clinical Pharmacology, EarlyView.Abstract Aim Although regulatory responses to safety signals have been studied, pregnancy‐specific data and their dissemination to medical professionals remain unclear. This study examined the characteristics and temporal trends of teratological safety signals prompting the European Medicines Agency to implement risk minimization measures.
Yrea R. J. van Rijt‐Weetink +9 more
wiley +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aim The number of pregnancies among women with cystic fibrosis (wwCF) has steadily increased over the past decade. However, the pharmacokinetics (PK) of elexacaftor–tezacaftor–ivacaftor (ETI) during gestation remains uncharacterized, despite its widespread use in this population.
Paulette Magnas +16 more
wiley +1 more source